id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-P-0108-0004,FDA,FDA-2007-P-0108,Nonprescription Drugs Advisory Committee; Notice of Meeting,Notice,Meeting,2007-10-24T04:00:00Z,2007,10,2007-10-24T04:00:00Z,2007-12-31T04:59:59Z,2025-07-09T23:09:12Z,07-5249,0,0,0900006480429e46
FDA-2007-P-0108-0003,FDA,FDA-2007-P-0108,Interim Response letter from FDA/CDER to the University of Florida,Other,Letter(s),2007-09-10T04:00:00Z,2007,9,,,2025-07-09T21:15:43Z,,0,0,0900006480429e45
FDA-2007-P-0108-0002,FDA,FDA-2007-P-0108,Acknowledgement Letter from FDA/DMB to University of Florida,Other,Acknowledgement Letter/Receipt,2007-02-08T05:00:00Z,2007,2,,,2025-03-03T20:12:57Z,,0,0,0900006480429e43
FDA-2007-P-0108-0001,FDA,FDA-2007-P-0108,Acknowledgement Letter from FDA/DMB to University of Florida,Other,Acknowledgement Letter/Receipt,2007-02-08T05:00:00Z,2007,2,,,2025-07-09T21:07:57Z,,0,0,0900006480429e3a